Auxilium

News

This section provides essential news and information about Auxilium.

  • Press Releases - get the latest corporate information about Auxilium
  • Archive - see a complete listing of past press releases about Auxilium
  • Investor Kit - contact us to receive the latest investor relations information

For Investors - additional information and resources designed with investors in mind.

Recent News
DateTitle 
Sep 17, 2014Auxilium Responds To Unsolicited Proposal From Endo International
Adopts One Year Stockholder Rights Plan CHESTERBROOK, Pa., Sept. 17, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today confirmed that Auxilium has received an unsolicited, non-binding proposal from Endo International plc (NASDAQ: ENDP) to acquire all of the outstanding shares of Auxilium common stock at a price of $28.10 per share in cash and Endo stock, subject to due diligence, financing and other conditions. A copy of the uns... 
Printer Friendly Version
Sep 9, 2014Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth
- Expected to Reduce Annual Operating Expenses by At Least $75 Million - - Focus on Targeted R&D Spend, Consolidated Commercial Operations, Improved Manufacturing Efficiency and Streamlined G&A Expenses - CHESTERBROOK, Pa., Sept. 9, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced steps it is taking to reduce its costs and more fully support the Company's goal to drive earnings growth and build shareholder ... 
Printer Friendly Version
Aug 28, 2014Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting
Study Results of Concurrent CCH Injections to Treat Two Dupuytren's Contracture Cords with Delayed Finger Extension Selected for Best Paper Session; Data Support Safe and Effective Use of CCH for Treatment of Two Affected Joints Concurrently CHESTERBROOK, Pa. , Aug. 28, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of collagenase clostridiu... 
Printer Friendly Version
Aug 27, 2014Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference
CHESTERBROOK, Pa., Aug. 27, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Morgan Stanley Healthcare Conference to be held September 8-10, 2014 in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 10:55 a.m. ET on Wednesday, September 1... 
Printer Friendly Version